Lansdowne Partners (UK)’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-1,459,706
| Closed | -$11.8M | – | 31 |
|
|
2019
Q1 | $11.8M | Sell |
1,459,706
-1,188,275
| -45% | -$9.61M | 0.26% | 25 |
|
|
2018
Q4 | $16.7M | Hold |
2,647,981
| – | – | 0.25% | 19 |
|
|
2018
Q3 | $26.1M | Hold |
2,647,981
| – | – | 0.28% | 20 |
|
|
2018
Q2 | $22M | Hold |
2,647,981
| – | – | 0.21% | 23 |
|
|
2018
Q1 | $19.1M | Hold |
2,647,981
| – | – | 0.2% | 18 |
|
|
2017
Q4 | $21.6M | Hold |
2,647,981
| – | – | 0.2% | 17 |
|
|
2017
Q3 | $38.4M | Hold |
2,647,981
| – | – | 0.4% | 13 |
|
|
2017
Q2 | $32M | Buy |
2,647,981
+326,116
| +14% | +$3.95M | 0.28% | 17 |
|
|
2017
Q1 | $29.8M | Hold |
2,321,865
| – | – | 0.26% | 16 |
|
|
2016
Q4 | $28.2M | Hold |
2,321,865
| – | – | 0.25% | 15 |
|
|
2016
Q3 | $21.3M | Hold |
2,321,865
| – | – | 0.18% | 13 |
|
|
2016
Q2 | $22M | Hold |
2,321,865
| – | – | 0.21% | 16 |
|
|
2016
Q1 | $16.4M | Hold |
2,321,865
| – | – | 0.13% | 17 |
|
|
2015
Q4 | $24.3M | Hold |
2,321,865
| – | – | 0.17% | 18 |
|
|
2015
Q3 | $15.5M | Hold |
2,321,865
| – | – | 0.13% | 17 |
|
|
2015
Q2 | $15.6M | Hold |
2,321,865
| – | – | 0.13% | 17 |
|
|
2015
Q1 | $15.7M | Hold |
2,321,865
| – | – | 0.14% | 19 |
|
|
2014
Q4 | $18.6M | Hold |
2,321,865
| – | – | 0.17% | 24 |
|
|
2014
Q3 | $8.17M | Hold |
2,321,865
| – | – | 0.07% | 30 |
|
|
2014
Q2 | $11.1M | Buy |
+2,321,865
| New | +$11.1M | 0.11% | 30 |
|